Antimicrobial Use and Risk for Recurrent Clostridium difficile Infection

This publication has 28 references indexed in Scilit:

• Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)
  Infection Control & Hospital Epidemiology, 2010
• Appropriateness of Urinary Tract Infection Diagnosis and Treatment Duration
  Archives of internal medicine (1960), 2010
• Treatment with Monoclonal Antibodies againstClostridium difficileToxins
  New England Journal of Medicine, 2010
• Antimicrobial prescribing in hospitals: be careful what you measure
  Journal of Antimicrobial Chemotherapy, 2009
• Inappropriate Treatment of Catheter‐Associated Asymptomatic Bacteriuria in a Tertiary Care Hospital
  Clinical Infectious Diseases, 2009
• The Hawthorne Effect: a randomised, controlled trial
  BMC Medical Research Methodology, 2007
• An Outbreak of Severe Clostridium difficile–Associated Disease Possibly Related to Inappropriate Antimicrobial Therapy for Community-Acquired Pneumonia
  Infection Control & Hospital Epidemiology, 2007
• Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec
  Canadian Medical Association Journal, 2005
• Effect of antimicrobial agents on the ecological balance of human microflora
  The Lancet Infectious Diseases, 2001
• PROSPECTIVE RANDOMISED TRIAL OF METRONIDAZOLE VERSUS VANCOMYCIN FOR CLOSTRIDIUM-DIFFICILE-ASSOCIATED DIARRHOEA AND COLITIS
  The Lancet, 1983